The FDA has approved the game-changing first flu vaccine spray that can be self-administered!On Friday, September 20, the ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003.

The scheme lists a variety of recognised adverse health conditions that have been found to have resulted in some people as a ...

Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

Unfortunately, it isn’t GSK, but rival AstraZeneca. I’m not sure Astra even sees GSK ... as Haleon in 2022 was supposed to ...

The Australian ...

The Food and Drug Administration (FDA) has greenlit the first-ever self-administered flu vaccine, FluMist. The agency made the announcement on Friday, explaining that FluMist is a convenient nasal ...

U.S. regulators last month approved an updated COVID-19 vaccine that is designed to combat the recent virus strains and, ...

THE Department of Health (DOH) said on Saturday, September 21, 2024, that 64 percent of the remaining P27.3 billion unpaid ...

The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list. The prequalification approval is expected to facilitate ...